Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2020-10-07 Director's Dealing
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-10-07 English
10-Q
Interim / Quarterly Report Q2 2020
2020-08-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated August 11, 2020, from Pliant Therapeutics, Inc. It announces the issuance of a press release with financial results for the quarter ended June 30, 2020. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the document itself does not contain detailed financial statements or substantive financial data. The length is 3613 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document announcing the release of financial results without containing the full report itself should be classified as an Earnings Release (ER).
2020-08-11 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-07-10 English
SC 13G
Major Shareholding Notification
2020-06-15 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.